{"id":"https://openalex.org/W7225201765","doi":"https://doi.org/10.5281/zenodo.23922281","title":"EVALUATION OF THE RELATIONSHIP BETWEEN LABORATORY BIOMARKERS AND THROMBOTIC COMPLICATIONS IN ANTIPHOSPHOLIPID SYNDROME","display_name":"EVALUATION OF THE RELATIONSHIP BETWEEN LABORATORY BIOMARKERS AND THROMBOTIC COMPLICATIONS IN ANTIPHOSPHOLIPID SYNDROME","publication_year":2026,"publication_date":"2026-11-03","ids":{"openalex":"https://openalex.org/W7225201765","doi":"https://doi.org/10.5281/zenodo.23922281"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23922281","doi":"https://doi.org/10.5281/zenodo.23922281","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23922281","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23922281","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160556140","display_name":"Mirzoxid Sabitdjanovich Musakov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267534","display_name":"Tashkent State Medical University","ror":"https://ror.org/035cgyb19","country_code":"UZ","type":"education","lineage":["https://openalex.org/I4405267534"]}],"countries":["UZ"],"is_corresponding":false,"raw_author_name":"Musakov, Mirzoxid Sabitdjanovich","raw_affiliation_strings":["Department of Hematology, Transfusiology and Laboratory Medicine, Tashkent State Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Transfusiology and Laboratory Medicine, Tashkent State Medical University","institution_ids":["https://openalex.org/I4405267534"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160482096","display_name":"Risolat Maxkamovna Raimova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267534","display_name":"Tashkent State Medical University","ror":"https://ror.org/035cgyb19","country_code":"UZ","type":"education","lineage":["https://openalex.org/I4405267534"]}],"countries":["UZ"],"is_corresponding":false,"raw_author_name":"Raimova, Risolat Maxkamovna","raw_affiliation_strings":["First-Year Student, Faculty of General Medicine No. 1, Tashkent State Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First-Year Student, Faculty of General Medicine No. 1, Tashkent State Medical University","institution_ids":["https://openalex.org/I4405267534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405267534"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.87318506,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiphospholipid-syndrome","display_name":"antiphospholipid syndrome","score":1.0},{"id":"https://openalex.org/keywords/thrombotic-complications","display_name":"thrombotic complications","score":0.9419999718666077},{"id":"https://openalex.org/keywords/lupus-anticoagulant","display_name":"lupus anticoagulant","score":0.9620000123977661},{"id":"https://openalex.org/keywords/anticardiolipin-antibodies","display_name":"anticardiolipin antibodies","score":0.9940000176429749},{"id":"https://openalex.org/keywords/anti-beta2-glycoprotein-i-antibodies","display_name":"anti-beta2-glycoprotein I antibodies","score":0.9729999899864197},{"id":"https://openalex.org/keywords/d-dimer","display_name":"D-dimer","score":0.9549999833106995},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":1.0},{"id":"https://openalex.org/keywords/platelet-count","display_name":"platelet count","score":0.9909999966621399},{"id":"https://openalex.org/keywords/coagulopathy","display_name":"coagulopathy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/arterial-thrombosis","display_name":"arterial thrombosis","score":0.8460000157356262},{"id":"https://openalex.org/keywords/venous-thrombosis","display_name":"venous thrombosis","score":1.0},{"id":"https://openalex.org/keywords/thrombotic-risk-stratification","display_name":"thrombotic risk stratification","score":0.9110000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9211999773979187},{"id":"https://openalex.org/C2776874634","wikidata":"https://www.wikidata.org/wiki/Q582207","display_name":"Antiphospholipid syndrome","level":3,"score":0.6624000072479248},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.5845000147819519},{"id":"https://openalex.org/C3018762881","wikidata":"https://www.wikidata.org/wiki/Q3774511","display_name":"Anticardiolipin antibodies","level":3,"score":0.5055000185966492},{"id":"https://openalex.org/C2780022809","wikidata":"https://www.wikidata.org/wiki/Q5786759","display_name":"Lupus anticoagulant","level":3,"score":0.4763000011444092},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4749999940395355},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.42989999055862427},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.4293000102043152},{"id":"https://openalex.org/C3020404979","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk stratification","level":2,"score":0.39590001106262207},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.39239999651908875},{"id":"https://openalex.org/C2778555097","wikidata":"https://www.wikidata.org/wiki/Q382091","display_name":"Post-thrombotic syndrome","level":4,"score":0.38350000977516174},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.36730000376701355},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.3531000018119812},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.33399999141693115},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.328000009059906},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3257000148296356},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.30140000581741333},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.29670000076293945},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.29420000314712524},{"id":"https://openalex.org/C16124881","wikidata":"https://www.wikidata.org/wiki/Q5363933","display_name":"Coagulation testing","level":3,"score":0.2892000079154968},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.2581000030040741},{"id":"https://openalex.org/C2991741193","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thromboembolism","level":3,"score":0.257999986410141},{"id":"https://openalex.org/C2777466421","wikidata":"https://www.wikidata.org/wiki/Q1266890","display_name":"Vascular disease","level":2,"score":0.25780001282691956},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.2515999972820282}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23922281","doi":"https://doi.org/10.5281/zenodo.23922281","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23922281","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23922282","doi":"https://doi.org/10.5281/zenodo.23922282","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23922282","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23922281","doi":"https://doi.org/10.5281/zenodo.23922281","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23922281","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2084085262","https://openalex.org/W2734820656","https://openalex.org/W4403175591","https://openalex.org/W3152193828","https://openalex.org/W2010738009","https://openalex.org/W2071123871","https://openalex.org/W2193448584","https://openalex.org/W3205672064","https://openalex.org/W3126513742","https://openalex.org/W2064697339"],"abstract_inverted_index":{"This":[0],"article":[1],"examines":[2],"the":[3,22,40,85],"relationship":[4],"between":[5],"laboratory":[6,89],"biomarkers":[7],"and":[8,24,32,49,65,77,96],"thrombotic":[9,93],"complications":[10],"in":[11,52,69],"patients":[12,71,102],"with":[13,103],"antiphospholipid":[14],"syndrome":[15],"(APS).":[16],"Particular":[17],"attention":[18],"is":[19,80],"given":[20],"to":[21],"diagnostic":[23],"prognostic":[25],"significance":[26],"of":[27,42,58,75,87,101],"lupus":[28],"anticoagulant,":[29],"anticardiolipin":[30],"antibodies,":[31],"anti-beta-2-glycoprotein":[33],"I":[34],"antibodies.":[35],"The":[36,56,82],"study":[37],"also":[38],"considers":[39],"role":[41],"additional":[43],"hemostatic":[44],"parameters,":[45],"including":[46],"D-dimer,":[47],"fibrinogen,":[48],"platelet":[50],"count,":[51],"evaluating":[53],"coagulation":[54],"abnormalities.":[55],"importance":[57,86],"persistent":[59],"antibody":[60,63],"positivity,":[61],"triple-positive":[62],"profiles,":[64],"clinical":[66,99],"risk":[67,74,94],"factors":[68],"identifying":[70],"at":[72],"increased":[73],"arterial":[76],"venous":[78],"thrombosis":[79],"discussed.":[81],"findings":[83],"highlight":[84],"comprehensive":[88],"assessment":[90],"for":[91],"improving":[92],"stratification":[95],"supporting":[97],"individualized":[98],"management":[100],"APS.":[104]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}